Vinati Organics Limited Raises ATBS Capacity to 50,000 MT

Vinati Organics Limited commissioned the first phase of its ATBS expansion in FY26, increasing annual capacity from 40,000 MT to 50,000 MT. The expansion matters because ATBS is the company’s largest product, and management reported utilisation of about 75-80% of the added capacity by May 2026.

How did Vinati expand its ATBS capacity?

Vinati increased its stated annual ATBS production capacity by 10,000 MT through the first phase of a planned expansion. The phase was commissioned in November 2025 and took the plant’s capacity from 40,000 MT to 50,000 MT. ATBS is used in applications that require specialty chemical inputs, making the expansion relevant to Vinati’s existing product portfolio and customer base.

The company had earlier indicated that the ATBS expansion would be undertaken in two phases. Management described the first phase as an increase of about 25-30%, while the second phase was expected around a year later. The total capital expenditure budget for the ATBS brownfield expansion was stated at about ₹300 crore.

By May 2026, management said it was operating at around 75-80% of the 50,000 MT ATBS capacity. Actual production can vary based on product mix, since higher-purity grades may require more time to manufacture. Vinati has not disclosed a contracted order book for the expanded production, so future capacity cannot be treated as fully committed sales.

What are Vinati’s plans for the second ATBS phase?

Vinati expects the second phase of the ATBS project to become useful around October 2026, with a fuller financial contribution expected in FY28. Management has stated that it expects ATBS volumes to grow by about 15% annually over three years, supported by the capacity additions.

The next phase is part of a wider investment programme that also includes new specialty chemicals through Veeral Organics Private Limited, or VOPL, Vinati’s wholly owned subsidiary. VOPL’s planned capital expenditure exceeds ₹500 crore and covers products including MEHQ, guaiacol, anisole, 4-methoxyacetophenone and isoamylene derivatives.

The company has said that these products serve end markets such as polymerisation inhibitors, resins, flavours, fragrances, personal care and pharmaceuticals. However, the project expenditure should not be confused with Vinati’s total equity investment in VOPL. The source distinguishes between project spending and the group’s equity commitment, without disclosing a total equity-investment figure.

What do Vinati’s capex and operating figures show?

Vinati spent approximately ₹500 crore on capital expenditure in FY25 and ₹270 crore in FY26. At the end of March 2026, the group reported property, plant and equipment of ₹2,122 crore, along with ₹214 crore of capital work in progress for projects that were not yet ready for intended use.

The investments reflect a period of capacity building across ATBS and VOPL’s new-product programme. In its FY25 earnings call, Vinati said it had allocated about ₹400 crore towards capital expenditure during that year, including investments in VOPL. Earlier guidance had placed overall FY25 spending in the range of ₹500 crore to ₹570 crore, including operational capital expenditure.

How has the expansion affected Vinati’s financial position?

Vinati’s June 2026 quarter showed sales growth of 28%, while net profit rose 4.5%. The difference between sales and profit growth indicates that higher revenue did not translate proportionately into profit during the quarter. The provided information does not specify the reasons for the margin movement.

VOPL remained in an early stage of operations during FY26. The subsidiary generated revenue of ₹21.9 crore and reported a loss of ₹39.7 crore for the year. This places attention on the pace at which its newly commissioned products can contribute to revenue and operating performance.

Vinati has also said it commissioned about 33 megawatts of solar power as of May 2024. The company linked this capacity to lower dependence on conventional energy sources and reduced emissions. This is relevant for a chemical manufacturer with expanding plant operations, though no quantified cost savings were disclosed in the supplied information.

What should investors monitor in Vinati’s next update?

Vinati announced a board meeting for October 30, 2026, to consider unaudited Q2 and half-year FY2026 results. The update could provide further information on production, utilisation and the progress of the second ATBS phase, although the announcement itself did not provide financial results.

The key operating indicators remain ATBS volume growth, utilisation of the expanded plant, commissioning progress at VOPL and the financial contribution from new products. Management’s previous revenue guidance pointed to a roughly 20% CAGR over three years, led by ATBS, antioxidants and VOPL products, but this remains management guidance rather than reported performance.

Conclusion

Vinati has expanded its core ATBS capacity to 50,000 MT and reported meaningful use of the added plant capacity within FY26. At the same time, the group’s capital expenditure has increased its manufacturing asset base, while VOPL remains loss-making during its new-product rollout.

The next developments to watch are the expected usefulness of ATBS Phase II around October 2026, its fuller contribution in FY28 and Vinati’s scheduled board consideration of Q2 and half-year FY2026 results. Updates on VOPL revenue, losses and commissioning progress will also be relevant to assessing the broader investment programme.